| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/21/2011 | US7964597 Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 06/21/2011 | US7964596 Therapeutic compounds |
| 06/21/2011 | US7964595 Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension |
| 06/21/2011 | US7964594 Amino oxazine derivatives |
| 06/21/2011 | US7964593 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/21/2011 | US7964591 Pyridazine derivatives and their use as therapeutic agents |
| 06/21/2011 | US7964590 Cyclopamine lactam analogs and methods of use thereof |
| 06/21/2011 | US7964589 Injectable sterile pharmaceutical formulation containing at least two active principles |
| 06/21/2011 | US7964588 Method for the treatment of psoriasis |
| 06/21/2011 | US7964587 Tocopherol and tocotrienol aerosols |
| 06/21/2011 | US7964586 by solid phase extraction from pregnant mares urine; contacting the urine with polymeric adsorption resins sufficient to adsorb the estrogen derivatives in the urine, then separating the resulting resin loaded with the mixture, washing and eluting the derivatives |
| 06/21/2011 | US7964585 Composition and method of treating peripheral neuropathy |
| 06/21/2011 | US7964584 Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
| 06/21/2011 | US7964583 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| 06/21/2011 | US7964582 Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers |
| 06/21/2011 | US7964581 Use of difructose anhydride-containing composition |
| 06/21/2011 | US7964580 Nucleoside phosphoramidate prodrugs |
| 06/21/2011 | US7964579 Compositions and methods for topical delivery of oligonucleotides |
| 06/21/2011 | US7964577 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
| 06/21/2011 | US7964575 Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer |
| 06/21/2011 | US7964573 Using presence of single nucleotide polymorphism in transient receptor potential channel gene(TRPC) as diagnostic/prognostic tool in detecting idiopathic pulmonary arterial hypertension (IPAH) |
| 06/21/2011 | US7964569 Oligosaccharide mimetics such as {(1R,2R,3S)-2-[(6-Deoxy- alpha -L-Galactopyranosyl)Oxy]-3-Ethyl-Cyclohex-1-yl}2-O-Benzoyl-3-O-[(1S)-1-Carboxy-2-Cyclohexyl-Ethyl]- beta -D-Galactopyranoside |
| 06/21/2011 | US7964568 Synthesis of high molecular weight iron-saccharidic complexes |
| 06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
| 06/21/2011 | US7964220 Method for treating a mammal by administration of a compound having the ability to release CO |
| 06/21/2011 | US7964219 Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| 06/21/2011 | US7964218 Granular preparations for oral administration |
| 06/21/2011 | US7964217 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 06/21/2011 | US7964216 Orally administering to a patient a spaced drug delivery system, wherein first therapeutically active agent is released immediately and second therapeutically active agent is released as a pulse at predetermined time after administration |
| 06/21/2011 | US7964212 Effervescent compositions comprising phosphonates and methods related thereto |
| 06/21/2011 | US7964204 Isoxazolines for controlling invertebrate pests |
| 06/21/2011 | US7964202 Method for treatment of common acne |
| 06/21/2011 | US7964188 Use of placental alkaline phosphatase to promote skin cell proliferation |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 06/21/2011 | US7964183 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 06/21/2011 | US7964182 Pharmaceutical compositions comprising phosphate-binding polymer |
| 06/21/2011 | US7964181 Amino acid surrogates for peptidic constructs |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2649403C Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 06/21/2011 | CA2646962C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 06/21/2011 | CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 06/21/2011 | CA2635412C Agent for prophylaxis and treatment of asthenopia or pseudomyopia |
| 06/21/2011 | CA2633440C 1,3-dioxane carboxylic acids |
| 06/21/2011 | CA2632283C Polymorphs of a c-met/hgfr inhibitor |
| 06/21/2011 | CA2618682C Viral polymerase inhibitors |
| 06/21/2011 | CA2611086C Agent for inhibiting visceral fat accumulation |
| 06/21/2011 | CA2591314C Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives and their use in therapy |
| 06/21/2011 | CA2577144C Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors |
| 06/21/2011 | CA2572729C Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 06/21/2011 | CA2563000C Indene derivatives and process for the preparation thereof |
| 06/21/2011 | CA2553918C Pharmaceutical composition for promoting angiogenesis |
| 06/21/2011 | CA2546064C Percutaneous absorption type cerebral protective agent |
| 06/21/2011 | CA2527155C Cationic porphyrin derivatives and uses thereof |
| 06/21/2011 | CA2516270C Oxadiazoline and thiadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/21/2011 | CA2508250C Pharmaceutical product that aims to alleviate or cure the snoring of a moderate or severe snorer |
| 06/21/2011 | CA2507545C Use of furfural derivatives as anti-sickling agents |
| 06/21/2011 | CA2506082C Novel medicaments for the treatment of chronic obstructive pulmonary disease |
| 06/21/2011 | CA2499273C Inhalation compositions |
| 06/21/2011 | CA2497980C Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2492775C Polyalkylene glycol acid additives |
| 06/21/2011 | CA2487113C Tooth whitening strip products comprising peroxide at low density |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2483562C Heterotricyclyl-6-alkylidene-penems as beta-lactamase inhibitors |
| 06/21/2011 | CA2483303C Cinnamic acid amides |
| 06/21/2011 | CA2481602C Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2469801C Thiadiazoline derivative |
| 06/21/2011 | CA2465641C Phenoxy amine compounds and compositions for delivering active agents |
| 06/21/2011 | CA2463256C Silver salts of sucrose-octasulphate |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2460789C Acid amide derivatives, process for their production and pesticides containing them |
| 06/21/2011 | CA2454047C Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 06/21/2011 | CA2446429C Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 06/21/2011 | CA2444899C Substituted tetracycline compounds for the treatment of malaria |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/21/2011 | CA2439857C Caloporoside derivatives, process for their preparation and their use |
| 06/21/2011 | CA2431011C Compositions and methods of use for extracts of magnoliaceae plants |
| 06/21/2011 | CA2430934C A method of producing sustained-release preparations of a bioactive substance using high-pressure gas |
| 06/21/2011 | CA2430785C Antiperspirant product comprising bronsted acid containing co-gellant polymers |
| 06/21/2011 | CA2415159C Antimicrobial composition useful for the treatment of bovine mastitis |
| 06/21/2011 | CA2407556C Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 06/21/2011 | CA2396785C A medicinal aerosol formulation |
| 06/21/2011 | CA2396648C A medicinal aerosol formulation |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2370775C Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 06/21/2011 | CA2370323C Preparation for veterinary use for the prevention of ear diseases |
| 06/21/2011 | CA2370143C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2288222C Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 06/21/2011 | CA2258735C Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 06/21/2011 | CA2203857C Microparticles for delivery of nucleic acid |
| 06/21/2011 | CA2199474C Inhibitory or blocking agents of molecular generating and/or inducing functions |